After a few difficult years for early-stage deals, the angel investment market is finally showing signs of recovery. But according to the 2026 Angel Funders Report, this is not simply a return to the way things were before the market correction. Angel investors are coming back with more capital, greater selectivity, and a sharper focus on where their dollars can have the greatest impact.
Let’s take a deep dive into the numbers and assess how the angel investment market is shaping up.
Angel Capital Is Moving Again
ACA-reported angel investment increased 12% year over year, rising from $437 million in 2024 to $491.3 million in 2025. That follows a difficult period after the pandemic, when angel investment activity declined significantly between 2022 and 2024.
But there’s a deeper story behind the recovery. The truth is, the capital is concentrated in a few companies. So, while accumulated capital is high, the number of companies raising funds has declined over time. The result is a market that is recovering through quality rather than quantity.
For investors, selectivity is very important for their portfolio. The current environment rewards disciplined capital deployment rather than simply increasing the number of deals in a portfolio.
For entrepreneurs, it sends an equally important signal: while capital is becoming more available, competition for that capital remains high. Business leaders need to demonstrate why their company deserves a larger share of increasingly selective investor dollars.
Life Sciences Is Taking a Bigger Share of the Pie
One of the most significant shifts highlighted in the report is the growing prominence of life sciences.
Medical Devices, Pharma and Therapeutics, Digital Health, and Medical Diagnostics collectively accounted for nearly 47% of reported angel investment dollars in 2025, compared with 37% in 2024 and 31% in 2023.
The trend reflects a broader search for opportunities beyond an increasingly crowded AI market.
As Kristina Montague, Managing Partner at The JumpFund and Board Chair at the ACA, explained during her keynote at the Summer Investor Capital Expo 2026, venture capital has become heavily concentrated in AI, prompting angels to ask where innovation is still happening and where funding gaps exist. At the same time, government and university funding for life sciences innovation has pulled back, creating an opening for early-stage investors.
That doesn't mean angels are abandoning AI. Nearly two-thirds of reporting angel groups made at least one AI-related investment in 2025, with particular interest in applied AI, healthcare AI, and industry-specific solutions.
Instead, the data points toward a more diversified approach to opportunity.
Exits Are Showing Signs of Life
For years, one of the biggest concerns in early-stage investing has been the lack of exits. The latest data provides some reason for optimism.
Angel investing in 2025 had an average exit multiple of approximately 2x, representing a slight improvement. Harvard Business Angels reported a 200x return on exit for an undisclosed company, demonstrating that significant exits are still happening.
That headline 200x exit is a reminder of the asymmetric nature of angel investing: a small number of exceptional outcomes can have an outsized impact on portfolio performance. But the report also shows that not every investment produces a win. Roughly 25% of reported exits returned less than 1X invested capital, underscoring the importance of portfolio construction and exit discipline.
Governance Could Be the Missing Piece
Perhaps one of the most important lessons for investors is not about where to invest, but how involved to be after investing.
The issue becomes particularly important as larger checks increasingly determine who gets more influence within a company. ACA research has found that angel groups receiving board seats typically invested about twice as much as groups without board representation.
For investors, this raises a strategic question: is writing a check enough, or does greater involvement create an opportunity to help shape the company's trajectory?
What the Recovery Means Going Forward
The 2026 data suggests that angel investing is entering a more mature phase.
Investors are writing larger checks, building portfolios more selectively, syndicating across regions, exploring sectors beyond traditional areas of focus, and paying closer attention to follow-on capital and exits. Kristina Montague identified five priorities for angel leaders: capital deployment, syndication, governance, sector strategy, and portfolio outcomes.
Angel investing is back. But the 2026 Angel Funders Report makes clear that the next phase will be defined not by how much capital enters the market, but by how thoughtfully that capital is deployed.
*This article is inspired by Kristina Montague’s keynote “ACA 2026 Update & Angel Funders Report Update” at the Summer Investor Capital Expo 2026.